We find that CASZ1 cross-talks with critical neural crest lineage regulators and noradrenergic NB CRC components such as HAND2, GATA3 and TBX2 to suppress NB growth and enhance noradrenergic neuronal differentiation. This evidence concerns the gene CASZ1 and colorectal carcinoma.